A Clinical Study of SYS6023 Combination Therapy for Advanced Breast Cancer

Clinical trial NCT07597629 · RECRUITING

Trial details

NCT number: NCT07597629
Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2026-05-25
Primary completion: 2027-11-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.